Novavax IncNASDAQ:NVAX
- LAST PRICE7.1350
- TODAY'S CHANGE (%)-0.0850 (-1.1773%)
- Bid / Lots7.1300/ 11
- Ask / Lots7.1400/ 27
- Open / Previous Close7.1400 / 7.2200
- Day Range
- 52 Week Range
- Volume4,464,600
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NVAX |
|---|---|---|
| 09:32 ET | 200463 | 7.19 |
| 09:33 ET | 65541 | 7.06 |
| 09:35 ET | 255768 | 7.03 |
| 09:37 ET | 306936 | 6.97 |
| 09:39 ET | 167842 | 6.92 |
| 09:42 ET | 142367 | 6.89 |
| 09:44 ET | 111043 | 6.85 |
| 09:46 ET | 76509 | 6.96 |
| 09:48 ET | 73713 | 6.915 |
| 09:50 ET | 119871 | 6.975 |
| 09:51 ET | 220242 | 7.06 |
| 09:53 ET | 62467 | 7.03 |
| 09:55 ET | 22541 | 7.01 |
| 09:57 ET | 55378 | 7.0408 |
| 10:00 ET | 37052 | 7.0325 |
| 10:02 ET | 50957 | 7.07 |
| 10:04 ET | 80390 | 7.005 |
| 10:06 ET | 39073 | 7.0134 |
| 10:08 ET | 38433 | 7.01 |
| 10:09 ET | 38366 | 6.98 |
| 10:11 ET | 158108 | 7.035 |
| 10:13 ET | 50519 | 7.135 |
| 10:15 ET | 67353 | 7.1317 |
| 10:18 ET | 46353 | 7.11 |
| 10:20 ET | 32208 | 7.09 |
| 10:22 ET | 33724 | 7.05 |
| 10:24 ET | 28029 | 7.1 |
| 10:26 ET | 61763 | 7.08 |
| 10:27 ET | 31869 | 7.055 |
| 10:29 ET | 57407 | 7.13 |
| 10:31 ET | 76912 | 7.16 |
| 10:33 ET | 38691 | 7.135 |
| 10:36 ET | 16219 | 7.1041 |
| 10:38 ET | 28884 | 7.09 |
| 10:40 ET | 16465 | 7.1 |
| 10:42 ET | 27239 | 7.075 |
| 10:44 ET | 41080 | 7.105 |
| 10:45 ET | 22674 | 7.1011 |
| 10:47 ET | 33236 | 7.06 |
| 10:49 ET | 21866 | 7.07 |
| 10:51 ET | 76921 | 7.085 |
| 10:54 ET | 43629 | 7.065 |
| 10:56 ET | 24615 | 7.045 |
| 10:58 ET | 19158 | 7.04 |
| 11:00 ET | 24323 | 7.031 |
| 11:02 ET | 14046 | 7.015 |
| 11:03 ET | 27113 | 7.06 |
| 11:05 ET | 14300 | 7.035 |
| 11:07 ET | 12644 | 7.05 |
| 11:09 ET | 13545 | 7.045 |
| 11:12 ET | 139216 | 7.12 |
| 11:14 ET | 65056 | 7.125 |
| 11:16 ET | 23309 | 7.14 |
| 11:18 ET | 14572 | 7.145 |
| 11:20 ET | 12752 | 7.115 |
| 11:21 ET | 9668 | 7.11 |
| 11:23 ET | 26331 | 7.135 |
| 11:25 ET | 9993 | 7.13 |
| 11:27 ET | 14683 | 7.12 |
| 11:30 ET | 13650 | 7.115 |
| 11:32 ET | 10078 | 7.095 |
| 11:34 ET | 9385 | 7.0799 |
| 11:36 ET | 18382 | 7.07 |
| 11:38 ET | 7700 | 7.075 |
| 11:39 ET | 14347 | 7.06 |
| 11:41 ET | 9720 | 7.05 |
| 11:43 ET | 29972 | 7.07 |
| 11:45 ET | 21346 | 7.075 |
| 11:48 ET | 5747 | 7.0776 |
| 11:50 ET | 15444 | 7.075 |
| 11:52 ET | 9521 | 7.09 |
| 11:54 ET | 13623 | 7.12 |
| 11:56 ET | 7779 | 7.125 |
| 11:57 ET | 7297 | 7.125 |
| 11:59 ET | 11882 | 7.135 |
Today
DJ Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too -- WSJ, from 3 hours ago by Dow Jones
3 hours ago by Dow JonesNovavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4), from 4 hours ago by Dow Jones
4 hours ago by Dow JonesDJ U.S. Vaccine Stocks Fall After Trump Picks Vaccine Skeptic RFK Jr as Health Department Head-- Market Talk, from 6 hours ago by Dow Jones
6 hours ago by Dow JonesDJ Trump Taps Vaccine Skeptic RFK Jr. to Lead HHS. Moderna and Novavax Stocks Slide. -- Barrons.com, from 6 hours ago by Dow Jones
6 hours ago by Dow JonesDJ These Stocks Are Moving the Most Today: Applied Materials, Tesla, Palantir, Pfizer, Domino's Pizza, Alibaba, and More -- Barrons.com, from 7 hours ago by Dow Jones
7 hours ago by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Novavax Inc | 1.2B | -3.2x | --- |
P3 Health Partners Inc | 74.9M | -0.3x | --- |
Azenta Inc | 2.1B | -14.2x | --- |
ACADIA Pharmaceuticals Inc | 2.8B | 21.5x | --- |
Inotiv Inc | 71.0M | -0.7x | --- |
Sinovac Biotech Ltd | 639.9M | -4.9x | --- |
Company Information
Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Contact Information
- Headquarters
- 700 Quince Orchard RoadGAITHERSBURG, MD, United States 20878
- Phone
- 240-268-2000
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- James Young
- President, Chief Executive Officer, Director
- John Jacobs
- President, Chief Operating Officer
- John Trizzino
- Chief Financial Officer, Executive Vice President, Treasurer
- James Kelly
- Executive Vice President, Chief Legal Officer, Company Secretary
- Mark Casey
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
|---|---|
Revenue (TTM) | $885.2M |
Shares Outstanding | 160.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.01 |
EPS | $-2.26 |
Book Value | $-5.14 |
P/E Ratio | -3.2x |
Price/Sales (TTM) | 1.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -34.05% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
